West Pharmaceutical Services, Inc. entered into a new $2.8 billion credit agreement dated October 26, 2026, with banks, including Bank of America, JPMorgan Chase, U.S. Bank, and Wells Fargo, to support its global operations. This Instrument is a critical development for the company's 2026-2027 capital management strategy.